Davide Bedognetti

11PUBLICATIONS
113CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiologically active moleculesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 10, 2026
Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions.

|Jul 07, 2025
Facts and Hopes: CAR T-Cell Therapy and Immune Contexture in Non-Hodgkin Lymphoma.

Assia Hijazi, Frederick L Locke, Nathalie Scholler

|Nov 30, 2023
Author Correction: Positive regulation of oxidative phosphorylation by nuclear myosin 1 protects cells from metabolic reprogramming and tumorigenesis in mice.

Tomas Venit, Oscar Sapkota, Wael Said Abdrabou

|Oct 10, 2023
Positive regulation of oxidative phosphorylation by nuclear myosin 1 protects cells from metabolic reprogramming and tumorigenesis in mice.

Tomas Venit, Oscar Sapkota, Wael Said Abdrabou

|Sep 22, 2023
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.

Teresa Maria Rosaria Noviello, Anna Maria Di Giacomo, Francesca Pia Caruso

|Jun 09, 2023
V

Laura Fusco, Arianna Gazzi, Christopher E Shuck

Pageof 2

Frequent Collaborators

3 joint publications

Wouter Hendrickx

3 joint publications

Jérôme Galon

3 joint publications

Darawan Rinchai

2 joint publications

Tariq Masoodi